PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.35 +0.01 (+2.94%)
At close: Oct 22, 2026 · 4:00 PM EDT

PharmaCyte Biotech (PMCB) Notes Payables (2011 - 2012)

Updated

PharmaCyte Biotech (PMCB) recorded Notes Payables of $2.21 million in fiscal Q3 2012 (quarter ended Jan 31, 2012), down 6.5% from the prior quarter.

Analysis

PharmaCyte Biotech (PMCB) Notes Payables (2011 - 2012) Analysis & Trends

At the end of FY2011 (ended Apr 30, 2011), PharmaCyte Biotech reported Notes Payables of $2.37 million.

  • Per Business Quant, the preceding three fiscal quarters came in at $2.37 million (Q2 2012), $2.37 million (Q1 2012) and $2.37 million (Q4 2011).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 PharmaCyte Biotech 3.76 Mn -69.08 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2012 2.21 Mn
Oct 31, 2011 2.37 Mn
Jul 31, 2011 2.37 Mn
Apr 30, 2011 2.37 Mn
API Access

PharmaCyte Biotech Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=PMCB&period=max&api_key=YOUR_API_KEY